ENGN · NASDAQ · Biotechnology

enGene Therapeutics (ENGN)

Develops non-viral genetic medicines led by a bladder-cancer therapy candidate.

$2.02
vs last close−0.04 (−1.71%)

13F · 13D/G · Form 4

Institutions74.26%49.76M shares
66 holders · as of Jun 30, 2026
Insiders6.80%4.56M shares
5 holders · as of Jul 22, 2026
Strategic holders10.97%7.35M shares
2 holders · as of Nov 18, 2025
Other7.97%5.35M shares
remainder

67.02M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
FCPM Iii Services B.V.Institution
14.37%9.63Mas of Jun 30, 2026
BML Capital Management, LLCInstitution
9.95%6.67Mas of Jun 30, 2026
BML Investment Partners, L.P.Institution
9.95%6.67Mfiled May 14, 2026
Siren, L.L.C.Institution
9.34%6.26Mas of Jun 30, 2026
Perceptive Advisors LLCInstitution
7.20%4.82Mas of Jun 30, 2026
Venrock Healthcare Capital Partners III, L.P.Institution
7.12%4.77Mfiled Feb 17, 2026
Invus Public Equities, L.P.Insider
6.73%4.51Mfiled May 5, 2026
Deep Track Capital, LPStrategic
6.44%4.32Mfiled Nov 18, 2025
Forbion Growth Opportunities Fund I Cooperatief U.A.Strategic10 percent owner
4.52%3.03Mfiled Nov 1, 2024
Ameriprise Financial IncInstitution
3.99%2.68Mas of Jun 30, 2026
Nextech Invest, Ltd.Institution
3.47%2.32Mas of Jun 30, 2026
Adar1 Capital Management, LLCInstitution
3.14%2.10Mas of Jun 30, 2026
Vestal Point Capital, LPInstitution
2.49%1.67Mas of Jun 30, 2026
Acorn Capital Advisors, LLCInstitution
1.90%1.27Mas of Jun 30, 2026
Peapod Lane Capital LLCInstitution
1.64%1.10Mas of Jun 30, 2026
Balyasny Asset Management L.P.Institution
1.50%1.01Mas of Jun 30, 2026
Millennium Management LLCInstitution
1.44%966,627as of Jun 30, 2026
Omega Fund Management, LLCInstitution
1.31%876,357as of Jun 30, 2026
Renaissance Technologies LLCInstitution
1.24%829,700as of Jun 30, 2026
Sr One Capital Management, LPInstitution
1.12%747,750as of Jun 30, 2026
Citadel Advisors LLCInstitution
1.07%717,686as of Jun 30, 2026
Affinity Asset Advisors, LLCInstitution
0.90%600,000as of Jun 30, 2026
UBS Group AGInstitution
0.76%509,087as of Jun 30, 2026
Eversept Partners, LPInstitution
0.70%469,584as of Jun 30, 2026
Kynam Capital Management, LPInstitution
0.68%457,855as of Jun 30, 2026

13F, as of Jun 30, 2026

66 holders · 49.76M shares · 22 new positions · 36 increased · 17 reduced · 21 closed

HolderShares% outstandingChg q/qFiled
FCPM Iii Services B.V.9.63M14.37%0Aug 14, 2026
BML Capital Management, LLC6.67M9.95%+6.67MnewAug 7, 2026
Siren, L.L.C.6.26M9.34%+6.26MnewAug 13, 2026
Perceptive Advisors LLC4.82M7.20%+4.82MnewAug 14, 2026
Ameriprise Financial Inc2.68M3.99%+2.68MnewAug 14, 2026
Nextech Invest, Ltd.2.32M3.47%+2.32MnewAug 14, 2026
Adar1 Capital Management, LLC2.10M3.14%+2.10MnewAug 14, 2026
Vestal Point Capital, LP1.67M2.49%+1.67MnewAug 14, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Perceptive Advisors LLC9.99%6.77M13GNov 18, 2025
BML Investment Partners, L.P.9.95%6.67M13GMay 14, 2026
Venrock Healthcare Capital Partners III, L.P.7.10%4.77M13GFeb 17, 2026
Invus Public Equities, L.P.6.70%4.51M13GMay 5, 2026
Deep Track Capital, LP6.69%4.32M13GNov 18, 2025
Phillip Grossincl. Robert Atchinson, Adage Capital Management, L.P.5.27%2.33M13GNov 12, 2024

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.